Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Integrating influenza antigenic dynamics with molecular evolution.

Bedford T, Suchard MA, Lemey P, Dudas G, Gregory V, Hay AJ, McCauley JW, Russell CA, Smith DJ, Rambaut A.

Elife. 2014;3:e01914. doi: 10.7554/eLife.01914. Epub 2014 Feb 4.

2.

Antigenic and genetic variation in the hemagglutinins of H1N1 and H3N2 human influenza a viruses in the Shanghai area from 2005 to 2008.

Ren XW, Ju LW, Yang JX, Lv XH, Jiang LF, Zhao NQ, Jiang QW.

J Med Virol. 2011 Jul;83(7):1113-20. doi: 10.1002/jmv.22078. Epub 2011 Apr 22.

PMID:
21520138
3.

[The spread and biological properties of epidemic influenza viruses A and B strains circulating in the 2006-2007 season in Russia].

Ivanova VT, Kurochkina IaE, Burtseva EI, Oskerko TA, Trushakova SV, Shevchenko ES, Cherkasov EG, Shchelkanov MIu, Matiushina RO, Kolobukhina LV, Feodoritova EL, Slepushkin AN.

Vopr Virusol. 2008 Sep-Oct;53(5):19-23. Russian.

PMID:
19069788
4.

[Evolutionary variability of influenza B viruses in Russian Federation in 2005-2012].

Lobova TG, Prokopets AV, Komissarov AB, Danilenko DM, Paiankova AA, Sukhovetskaia VF, Gudkova TM, Grigor'eva VA, Grudinin MP, Eropkin MIu.

Vopr Virusol. 2012 Nov-Dec;57(6):22-6. Russian.

PMID:
23477250
5.

Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.

Ann J, Papenburg J, Bouhy X, Rhéaume C, Hamelin MÈ, Boivin G.

J Clin Virol. 2012 Jan;53(1):88-92. doi: 10.1016/j.jcv.2011.09.016. Epub 2011 Oct 28.

PMID:
22036039
6.

Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.

Andrews N, McMenamin J, Durnall H, Ellis J, Lackenby A, Robertson C, von Wissmann B, Cottrell S, Smyth B, Moore C, Gunson R, Zambon M, Fleming D, Pebody R.

Euro Surveill. 2014 Jul 10;19(27):5-13.

7.

Diversifying Selection Analysis Predicts Antigenic Evolution of 2009 Pandemic H1N1 Influenza A Virus in Humans.

Lee AJ, Das SR, Wang W, Fitzgerald T, Pickett BE, Aevermann BD, Topham DJ, Falsey AR, Scheuermann RH.

J Virol. 2015 May;89(10):5427-40. doi: 10.1128/JVI.03636-14. Epub 2015 Mar 4.

8.

Vaccination and antigenic drift in influenza.

Boni MF.

Vaccine. 2008 Jul 18;26 Suppl 3:C8-14. Review.

9.

Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.

de Jong JC, Smith DJ, Lapedes AS, Donatelli I, Campitelli L, Barigazzi G, Van Reeth K, Jones TC, Rimmelzwaan GF, Osterhaus AD, Fouchier RA.

J Virol. 2007 Apr;81(8):4315-22. Epub 2007 Feb 7.

10.

Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay J, Fonseca K, Charest H, Krajden M, Petric M, Mahmud SM, Van Caeseele P, Bastien N, Eshaghi A, Li Y.

J Infect Dis. 2015 Sep 1;212(5):726-39. doi: 10.1093/infdis/jiv177. Epub 2015 Mar 17.

PMID:
25784728
11.

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.

Skowronski DM, Janjua NZ, De Serres G, Sabaiduc S, Eshaghi A, Dickinson JA, Fonseca K, Winter AL, Gubbay JB, Krajden M, Petric M, Charest H, Bastien N, Kwindt TL, Mahmud SM, Van Caeseele P, Li Y.

PLoS One. 2014 Mar 25;9(3):e92153. doi: 10.1371/journal.pone.0092153. eCollection 2014.

12.

Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season.

[No authors listed]

Wkly Epidemiol Rec. 2010 Mar 5;85(10):81-92. English, French. No abstract available.

13.

Etiology of influenza viruses isolated in Russia from 1998 up to present time.

Konovalova NI, Litvinova OM, Gudkova TM, Lobova TG, Grigorieva VA, Eropkin MU, Yaglovskaya IB.

Vaccine. 2006 Nov 10;24(44-46):6697-700. Epub 2006 Jun 19.

PMID:
16920234
14.

Recommended composition of influenza virus vaccines for use in the 2015 southern hemisphere influenza season.

[No authors listed]

Wkly Epidemiol Rec. 2014 Oct 10;89(41):441-52. English, French. No abstract available.

15.

Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance.

Skowronski DM, Hamelin ME, Janjua NZ, De Serres G, Gardy JL, Rhéaume C, Bouhy X, Boivin G.

PLoS One. 2012;7(6):e38929. doi: 10.1371/journal.pone.0038929. Epub 2012 Jun 22.

16.

[Molecular characterization of human influenza viruses--a look back on the last 10 years].

Schweiger B.

Berl Munch Tierarztl Wochenschr. 2006 Mar-Apr;119(3-4):167-78. Review. German.

PMID:
16573207
17.

Recommended composition of influenza virus vaccines for use in the 2013–2014 northern hemisphere influenza season.

[No authors listed]

Wkly Epidemiol Rec. 2013 Mar 8;88(10):101-14. English, French. No abstract available.

18.

Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine.

Skowronski DM, Janjua NZ, Sabaiduc S, De Serres G, Winter AL, Gubbay JB, Dickinson JA, Fonseca K, Charest H, Bastien N, Li Y, Kwindt TL, Mahmud SM, Van Caeseele P, Krajden M, Petric M.

J Infect Dis. 2014 Jul 1;210(1):126-37. Epub 2014 Jan 19.

19.

Recommended composition of influenza virus vaccines for use in the 2013 southern hemisphere influenza season.

[No authors listed]

Wkly Epidemiol Rec. 2012 Oct 12;87(41):389-400. English, French. No abstract available.

20.

Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.

Lewis NS, Anderson TK, Kitikoon P, Skepner E, Burke DF, Vincent AL.

J Virol. 2014 May;88(9):4752-63. doi: 10.1128/JVI.03805-13. Epub 2014 Feb 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk